Living Tumor Laboratory / DrugBank / Creative Commons / /
Country
Canada / / /
Event
FDA Phase / /
Facility
University of British Columbia / Living Tumor Laboratory / /
IndustryTerm
chemical marks / large network / particular chemical mark / chemical modifications / /
MedicalCondition
genes prostate tumors / PCa tumor / epithelial lung cancer / neuroendocrine prostate cancer / small cell lung cancer / colon cancer / high-grade tumors / aggressive neuroendocrine tumors / SCLC / NEPC tumor / xenograft tumor / each tumor / prostate cancer / lung adenocarcinoma / invariably lethal disease / adenocarcinoma / NEPC patient tumors / tumor / both tumor / squamous cell carcinoma / cancer / lethal disease / tumors / disease / human cancer / neuroendocrine tumor / aggressive tumor / aggressive disease / lung cancer / NEPC (LTL331R) tumor / /
OperatingSystem
L3 / /
Organization
Department of Experimental Therapeutics / Faculty of Medicine / PRC1 / PcG / Living Tumor Lab / PRC1 and PRC2 / FDA / PRC2 / British Columbia Cancer Research Centre / CBX / University of British Columbia / at disrupting altered PcG-mediated silencing / /